Fossil Group, Inc.
For the period ended Oct 4, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 4, 2025 · Filed Nov 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
- FINANCIAL STATEMENT POLICIES
Basis of Presentation. The condensed consolidated financial statements include the accounts of Fossil Group, Inc., a Delaware corporation, and its wholly and majority-owned subsidiaries (the “Company”).
The Company’s fiscal year periodically results in a 53-week year instead of a normal 52-week year. The current fiscal year ending January 3, 2026 is a 53-week year, with the additional week being included in the quarter ended April 5, 2025. The information presented herein includes the thirteen-week period ended October 4, 2025 (“Third Quarter”) as compared to the thirteen-week period ended September 28, 2024 (“Prior Year Quarter”), and the forty week period ended October 4, 2025 ("Year To Date Period") as compared to the thirty-nine week period ended September 28, 2024 ("Prior Year YTD Period"). The condensed consolidated financial statements reflect all adjustments that are, in the opinion of management, necessary to present a fair statement of the Company’s financial position as of October 4, 2025, and the results of operations for the Third Quarter, Prior Year Quarter, Year To Date Period and Prior Year YTD Period. All adjustments are of a normal, recurring nature.
These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K filed by the Company pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), for the fiscal year ended December 28, 2024, as amended (the “2024 Form 10-K”). Operating results for the Third Quarter are not necessarily indicative of the results to be achieved for the full fiscal year.
The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), which require the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods reported. We base our estimates on the information available at the time and various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates. The Company has not made any changes in its significant accounting policies from those disclosed in the 2024 Form 10-K.
Business. The Company is a global design, marketing and distribution company that specializes in consumer fashion accessories. Its principal offerings include an extensive line of men's and women's fashion watches and jewelry, handbags, small leather goods, belts and sunglasses. In the watch and jewelry product categories, the Company has a diverse portfolio of globally recognized owned and licensed brand names under which its products are marketed. The Company's products are distributed globally through various distribution channels, including wholesale in countries where it has a physical presence, direct to the consumer through its retail stores and commercial websites and through third-party distributors in countries where the Company does not maintain a physical presence. The Company's products are offered at varying price points to meet the needs of its customers, whether they are value-conscious or luxury oriented. Based on its extensive range of accessory products, brands, distribution channels and price points, the Company is able to target style-conscious consumers across a wide age spectrum on a global basis.
Operating Expenses. Operating expenses include selling, general and administrative ("SG&A"), other long-lived asset impairments and restructuring charges. SG&A expenses include selling and distribution expenses primarily consisting of sales and distribution labor costs, sales distribution center and warehouse facility costs, depreciation expense related to sales distribution and warehouse facilities, the four-wall operating costs of the Company's retail stores, point-of-sale expenses, advertising expenses and art, and design and product development labor costs. SG&A also includes general and administrative expenses primarily consisting of administrative support labor and support costs such as treasury, legal, information services, accounting, internal audit, human resources, executive management costs and costs associated with stock-based compensation. Restructuring charges include costs to reduce and optimize the Company’s infrastructure and store closures. See Note 16— Restructuring for additional information on the Company’s restructuring plan.
Earnings (Loss) Per Share (“EPS”). Basic EPS is based on the weighted average number of common shares outstanding during each period. Diluted EPS adjusts basic EPS for the effects of dilutive common stock equivalents outstanding during each period using the treasury stock method.
The following table reconciles the numerators and denominators used in the computations of both basic and diluted EPS (in thousands, except per share data):
| For the 13 Weeks Ended October 4, 2025 | For the 13 Weeks Ended September 28, 2024 | For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 | |
|---|---|---|---|---|
| Numerator: | ||||
| Net income (loss) attributable to Fossil Group, Inc. | $(39,869) | $(32,031) | $(59,739) | $(95,112) |
| Denominator: | ||||
| Basic EPS computation: | ||||
| Basic weighted average common shares outstanding | 52,363 | 53,171 | 53,089 | 52,863 |
| Basic EPS | $(0.76) | $(0.60) | $(1.13) | $(1.80) |
| Diluted EPS computation: | ||||
| Diluted weighted average common shares outstanding | 52,363 | 53,171 | 53,089 | 52,863 |
| Diluted EPS | $(0.76) | $(0.60) | $(1.13) | $(1.80) |
Weighted average shares issuable under stock-based awards and warrants that were not included in the diluted EPS calculation because they were antidilutive were approximately 5.3 million and 4.0 million at the end of the Third Quarter and Year To Date Period, respectively. The total antidilutive weighted average shares included 1.2 million and 0.8 million weighted average performance-based shares at the end of the Third Quarter and Year To Date Period, respectively. The total antidilutive weighted average shares included 1.4 million and 0.5 million weighted average shares issuable under pre-funded warrants at the end of the Third Quarter and Year To Date Period, respectively.
At the end of the Prior Year Quarter and Prior Year YTD Period, approximately 1.4 million and 1.6 million weighted average shares issuable under stock-based awards, respectively, were not included in the diluted EPS calculation because they were antidilutive. The total antidilutive weighted average shares included 0.1 million and 0.2 million weighted average performance-based shares at the end of the Prior Year Quarter and Prior Year YTD Period, respectively.
Cash, Cash Equivalents and Restricted Cash. Restricted cash included in intangible and other assets-net was comprised primarily of pledged collateral to secure bank guarantees for the purpose of obtaining retail space and restricted cash from receivables buyout facilities. The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of October 4, 2025 and September 28, 2024 that are presented in the condensed consolidated statement of cash flows (in thousands):
| October 4, 2025 | September 28, 2024 | |
|---|---|---|
| Cash and cash equivalents | $79,216 | $106,308 |
| Restricted cash included in prepaid expenses and other current assets | 4,330 | 1,413 |
| Restricted cash included in intangible and other assets-net | 2,213 | 3,016 |
| Cash, cash equivalents and restricted cash | $85,759 | $110,737 |
Recently Issued Accounting Standards
In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU"), 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires entities to disclose additional information about specific expense categories in the notes to the financial statements at interim and annual reporting periods. This guidance is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. The adoption of this standard will result in additional disclosure in the notes to the financial statements.
The Organization for Economic Cooperation and Development ("OECD") and over 140 countries have agreed to enact a two-pillar solution to reform the international tax rules to address the challenges arising from the globalization and digitalization of the economy. "The Pillar Two Global Anti-Base Erosion (GloBE) Rules" provide a coordinated system to ensure that multinational enterprises with revenues above 750 million euro pay a minimum effective tax rate of 15% tax on the income arising in each of the jurisdictions in which they operate. Many aspects of Pillar Two became effective for tax years beginning in January 2024, with certain remaining impacts to be effective in 2025. Each country must enact its own legislation to apply the Pillar Two rules. Since becoming effective, Pillar Two has not had a material impact on the Company's financial results, including its annual estimated effective tax rate or liquidity. The Company will continue to monitor future developments in 2025.
Recently Adopted Accounting Standards
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures through changes to the rate reconciliation and income taxes paid information. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-09 in the first quarter of fiscal year 2025 on a prospective basis. The adoption of the updated guidance will result in additional disaggregation of certain tax information within the Company's income tax footnote disclosure in its Annual Report on Form 10-K.
- REVENUE
Disaggregation of Revenue. The Company's revenue disaggregated by major product category and timing of revenue recognition was as follows (in thousands):
| For the 13 Weeks Ended October 4, 2025 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Product type | |||||
| Watches: | |||||
| Traditional watches | $91,281 | $73,895 | $57,028 | $— | $222,204 |
| Smartwatches | 3,343 | 273 | 216 | — | 3,832 |
| Total watches | $94,624 | $74,168 | $57,244 | $— | $226,036 |
| Leathers | 9,547 | 1,591 | 3,956 | — | 15,094 |
| Jewelry | 3,975 | 13,825 | 7,257 | — | 25,057 |
| Other | 1,588 | 1,565 | 529 | 332 | 4,014 |
| Consolidated | $109,734 | $91,149 | $68,986 | $332 | $270,201 |
| Timing of revenue recognition | |||||
| Revenue recognized at a point in time | $109,697 | $91,084 | $68,942 | $332 | $270,055 |
| Revenue recognized over time | 37 | 65 | 44 | — | 146 |
| Consolidated | $109,734 | $91,149 | $68,986 | $332 | $270,201 |
| For the 13 Weeks Ended September 28, 2024 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Product type | |||||
| Watches: | |||||
| Traditional watches | $93,935 | $74,162 | $55,151 | $— | $223,248 |
| Smartwatches | 3,997 | (265) | 236 | — | 3,968 |
| Total watches | $97,932 | $73,897 | $55,387 | $— | $227,216 |
| Leathers | 14,186 | 3,561 | 6,199 | — | 23,946 |
| Jewelry | 7,273 | 17,528 | 6,658 | — | 31,459 |
| Other | 1,942 | 2,067 | 734 | 455 | 5,198 |
| Consolidated | $121,333 | $97,053 | $68,978 | $455 | $287,819 |
| Timing of revenue recognition | |||||
| Revenue recognized at a point in time | $121,243 | $96,912 | $68,861 | $455 | $287,471 |
| Revenue recognized over time | 90 | 141 | 117 | — | 348 |
| Consolidated | $121,333 | $97,053 | $68,978 | $455 | $287,819 |
| For the 40 Weeks Ended October 4, 2025 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Product type | |||||
| Watches: | |||||
| Traditional watches | $246,459 | $186,718 | $152,103 | $— | $585,280 |
| Smartwatches | 7,997 | 1,265 | 15 | — | 9,277 |
| Total watches | $254,456 | $187,983 | $152,118 | $— | $594,557 |
| Leathers | 30,015 | 5,927 | 13,279 | — | 49,221 |
| Jewelry | 13,783 | 36,452 | 16,473 | — | 66,708 |
| Other | 4,960 | 5,289 | 1,876 | 1,271 | 13,396 |
| Consolidated | $303,214 | $235,651 | $183,746 | $1,271 | $723,882 |
| Timing of revenue recognition | |||||
| Revenue recognized at a point in time | $303,069 | $235,424 | $183,568 | $1,271 | $723,332 |
| Revenue recognized over time | 145 | 227 | 178 | — | 550 |
| Consolidated | $303,214 | $235,651 | $183,746 | $1,271 | $723,882 |
| For the 39 Weeks Ended September 28, 2024 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Product type | |||||
| Watches: | |||||
| Traditional watches | $260,586 | $186,918 | $156,393 | $— | $603,897 |
| Smartwatches | 14,677 | 1,834 | 4,726 | — | 21,237 |
| Total watches | $275,263 | $188,752 | $161,119 | $— | $625,134 |
| Leathers | 49,857 | 11,703 | 17,135 | — | 78,695 |
| Jewelry | 19,418 | 43,218 | 19,286 | — | 81,922 |
| Other | 6,397 | 6,952 | 2,173 | 1,420 | 16,942 |
| Consolidated | $350,935 | $250,625 | $199,713 | $1,420 | $802,693 |
| Timing of revenue recognition | |||||
| Revenue recognized at a point in time | $350,637 | $250,174 | $199,370 | $1,420 | $801,601 |
| Revenue recognized over time | 298 | 451 | 343 | — | 1,092 |
| Consolidated | $350,935 | $250,625 | $199,713 | $1,420 | $802,693 |
Contract Balances. As of October 4, 2025, the Company hadno material contract assets on the Company's condensed consolidated balance sheets andno deferred contract costs. The Company had contract liabilities of $0.2 million and $0.7 million as of October 4, 2025 and December 28, 2024, respectively, primarily related to remaining performance obligations on wearable technology products and $1.7 million and $2.1 million as of October 4, 2025 and December 28, 2024, respectively, related to gift cards issued.
- INVENTORIES
Inventories consisted of the following (in thousands):
| October 4, 2025 | December 28, 2024 | |
|---|---|---|
| Components and parts | $9,036 | $12,322 |
| Finished goods | 157,813 | 166,254 |
| Inventories | $166,849 | $178,576 |
- WARRANTY LIABILITIES
The Company’s warranty liability is recorded in accrued expenses-other in the Company’s condensed consolidated balance sheets. Warranty liability activity consisted of the following (in thousands):
| For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 | |
|---|---|---|
| Beginning balance | $6,113 | $10,122 |
| Settlements in cash or kind | (3,006) | (3,795) |
| Warranties issued and adjustments to preexisting warranties (1) | 1,740 | 382 |
| Ending balance | $4,847 | $6,709 |
(1) Changes in cost estimates related to preexisting warranties are aggregated with accruals for new standard warranties issued and foreign currency changes.
- INCOME TAXES
The Company’s income tax (benefit) expense and related effective rates were as follows (in thousands, except percentage data):
| For the 13 Weeks Ended October 4, 2025 | For the 13 Weeks Ended September 28, 2024 | For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 | |
|---|---|---|---|---|
| Income tax (benefit) expense | $7,956 | $6,165 | $17,555 | $2,257 |
| Effective tax rate | (24.8)% | (23.9)% | (41.4)% | (2.4)% |
The effective tax rate in the Third Quarter differed from the Prior Year Quarter primarily due to a change in the Company’s global mix of earnings. In addition, income taxes were accrued on certain income in foreign jurisdictions and no tax benefit has been accrued on the U.S. tax losses and on certain losses in other foreign jurisdictions due to valuation allowances previously recorded. The effective tax rate can also vary from quarter-to-quarter due to changes in the resolution of income tax audits, changes in uncertain tax positions, and changes in tax law.
On July 4, 2025, the United States Congress passed the budget reconciliation bill H.R. 1, commonly referred to as the One Big Beautiful Bill Act ("OBBBA"). The OBBBA makes permanent many of the provisions previously enacted as part of the 2017 Tax Cut and Jobs Act that were set to expire at the end of 2025 and includes other changes to certain U.S. corporate tax provisions. The changes to U.S. tax law that were enacted under the OBBBA include modifications to capitalization of research and development expenses, limitations on deductions for interest expense and accelerated fixed asset depreciation. Based on our current U.S. tax position, we note no material tax impacts as a result of the changes introduced under the OBBBA.
As of October 4, 2025, the Company's total amount of unrecognized tax benefits, excluding interest and penalties, was $6.6 million, all of which would favorably impact the effective tax rate in future periods, if recognized. The Company released corresponding uncertain tax positions of $1.0 million in the first quarter of 2025. It is reasonably expected that certain uncertain tax positions will be resolved within the next 12 month period, and if resolved favorably, it would impact the tax rate by a benefit of approximately $3.1 million, including interest.
The Company is also subject to examinations in various state and foreign jurisdictions for its 2013-2024 tax years, none of which the Company believes are significant, individually or in the aggregate. Tax audit outcomes and timing of tax audit settlements are subject to significant uncertainty.
The Company has classified uncertain tax positions as long-term income taxes payable, unless such amounts are expected to be settled within twelve months of the condensed consolidated balance sheet date. As of October 4, 2025, the Company has not recorded any new unrecognized tax benefits, excluding interest and penalties, for positions that are expected to be settled within the next twelve months. Consistent with its past practice, the Company recognizes interest and/or penalties related to income tax overpayments and income tax underpayments in income tax expense and income taxes receivable/payable. At October 4, 2025, the total amount of accrued income tax-related interest expense, net included in the condensed consolidated balance sheets was $1.5 million. There were no accrued tax-related penalties.
- STOCKHOLDERS’ EQUITY
Common and Preferred Stock. The Company has 100,000,000 shares of common stock, par value $0.01 per share, ("Common Stock") authorized, with 53,847,092 and 53,253,974 shares issued and outstanding at October 4, 2025 and December 28, 2024, respectively. The Company has 1,000,000 shares of preferred stock, par value $0.01 per share, authorized, with none issued or outstanding at October 4, 2025 or December 28, 2024. Rights, preferences and other terms of preferred stock will be determined by the Board of Directors at the time of issuance.
Common Stock Repurchase Programs. Purchases of the Company’s common stock are made from time to time pursuant to its repurchase programs, subject to market conditions and at prevailing market prices, through the open market. Repurchased shares of common stock are recorded at cost and become authorized but unissued shares which may be issued in the future for general corporate or other purposes. The Company may terminate or limit its stock repurchase program at any time. In the event the repurchased shares are cancelled, the Company accounts for retirements by allocating the repurchase price to common stock, additional paid-in capital and retained (deficit) earnings. The repurchase price allocation is based upon the equity contribution associated with historical issuances. The repurchase programs are conducted pursuant to Rule 10b-18 of the Exchange Act.
Warrant Agreement. On August 13, 2025, the Company entered into a securities exchange agreement with certain institutional stockholders (the "Exchanging Stockholders”), pursuant to which the Company agreed to exchange an aggregate of 2,500,000 shares of the Company’s common stock, par value $0.01 per share (the "Surrendered Shares”), owned by the Exchanging Stockholders for pre-funded warrants (the "Exchange Warrants”) to purchase an aggregate of 2,500,000 shares of common stock with an exercise price of $0.01 per share. The Exchange Warrants will not expire prior to exercise. The Company also agreed to pay the Exchanging Stockholders an amount of $0.01 per share for the Surrendered Shares. The Exchange Warrants are exercisable at any time, except that the Exchange Warrants cannot be exercised by the Exchanging Stockholders if, after giving effect thereto, the Exchanging Stockholders would beneficially own more than 9.99% of the Company’s common stock, subject to certain exceptions.
As of October 4, 2025, the Company had $15.5 million of repurchase authorizations remaining under its repurchase program. The following table reflects the Company’s common stock repurchase activity for the period indicated (in millions):
| Fiscal YearAuthorized | Dollar ValueAuthorized | Termination Date | Number ofSharesRepurchased | Dollar ValueRepurchased |
|---|---|---|---|---|
| 2010 | $30.0 | None | 2.5 | $4.5 |
- EMPLOYEE BENEFIT PLANS
Restricted Stock Units and Performance Restricted Stock Units. The following table summarizes restricted stock unit and performance restricted stock unit activity during the Third Quarter:
| Restricted Stock Unitsand Performance Restricted Stock Units | Number of Shares | Weighted-AverageGrant Date FairValue Per Share |
|---|---|---|
| (in Thousands) | ||
| Nonvested at July 5, 2025 | 4,046 | $1.13 |
| Granted | 20 | 1.62 |
| Vested | (59) | 1.24 |
| Forfeited | (116) | 0.99 |
| Nonvested at October 4, 2025 | 3,891 | $1.15 |
The total fair value of restricted stock units vested was $0.2 million during the Third Quarter. Vesting of performance restricted stock units is based on the Company's stock market performance.
Long-Term Incentive Plans. On April 29, 2024, the Company's Board of Directors adopted the 2024 Long-Term Incentive Plan ("2024 Plan"), which was approved by the Company’s stockholders at the Company’s Annual Shareholder Meeting on June 21, 2024. The 2024 Plan replaces and supersedes the previously adopted 2016 Long-Term Incentive Plan. An aggregate of 7,000,000 shares of the Company's common stock were reserved for issuance pursuant to the Company's 2024 Plan.
Under the 2024 Plan, designated employees of the Company, including officers, certain contractors, and non-employee directors of the Company, are eligible to receive (i) stock options, (ii) stock appreciation rights, (iii) restricted or non-restricted stock awards, (iv) restricted stock units, (v) performance awards, (vi) cash awards, or (vii) any combination of the foregoing. The 2024 Plan is administered by The Compensation and Talent Management Committee (the "Compensation Committee"). Each award issued under the 2024 Plan terminates at the time designated by the Compensation Committee, not to exceedten years from the date of grant. The current outstanding stock options, stock appreciation rights, performance stock appreciation rights, restricted stock, restricted stock units and performance restricted stock units issued under the 2024 Plan predominantly have original vesting periods ofthree years. Time-based or performance-based stock appreciation rights and restricted stock units are predominately settled in shares of the Company's common stock. On the date of the Company’s annual stockholders meeting, each non-employee director is eligible to receive a grant of restricted stock units, in an amount determined by the Board, in its sole discretion, provided that the grant shall not exceed more than the number of shares of Common Stock having an aggregate fair market value of $130,000. Any such grant shall vest 100% on the earlier ofone year from the date of grant or the date of the Company's next annual stockholders meeting, provided such director is providing services to the Company or a subsidiary of the Company on that date.
Inducement Grants. On September 1, 2024, the Company's Board of Directors approved the grant of an employee inducement award consisting of 1,500,000 restricted stock units to the Company's new Chief Executive Officer. The restricted stock units vested 50% on October 15, 2025 with the balance to vest on October 15, 2026, subject to continuous employment with the Company through the vesting date.
During the Year To Date Period, the Company's Board of Directors approved the following grants of employee inducement awards:150,000 shares of restricted stock units to the Company's new Chief Financial Officer,129,581 shares of restricted stock units to the Company's new Chief Commercial Officer and 100,000 shares of restricted stock units to the Company's new Chief Digital Information Officer/General Manager EMEA. Each of these grants has athree-year vesting schedule, subject to the continuous employment with the Company by each new respective employee through each vesting date.
- ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The following tables disclose changes in the balances of each component of accumulated other comprehensive income (loss), net of taxes (in thousands):
| For the 13 Weeks Ended October 4, 2025 | ||||
|---|---|---|---|---|
| CurrencyTranslationAdjustments · Cash Flow Hedges | ||||
| ForwardContracts · PensionPlan · Total | ||||
| Beginning balance | $(67,882) | $1,338 | $4,268 | $(62,276) |
| Other comprehensive income (loss) before reclassifications | 1,653 | — | — | 1,653 |
| Amounts reclassed from accumulated other comprehensive income (loss) | — | — | — | — |
| Total other comprehensive income (loss) | 1,653 | — | — | 1,653 |
| Ending balance | $(66,229) | $1,338 | $4,268 | $(60,623) |
| For the 13 Weeks Ended September 28, 2024 | ||||
|---|---|---|---|---|
| CurrencyTranslationAdjustments · Cash Flow Hedges | ||||
| ForwardContracts · PensionPlan · Total | ||||
| Beginning balance | $(88,023) | $2,441 | $5,794 | $(79,788) |
| Other comprehensive income (loss) before reclassifications | 7,065 | (646) | — | 6,419 |
| Tax (expense) benefit | — | (2) | — | (2) |
| Amounts reclassed from accumulated other comprehensive income (loss) | — | 192 | — | 192 |
| Tax (expense) benefit | — | 16 | — | 16 |
| Total other comprehensive income (loss) | 7,065 | (856) | — | 6,209 |
| Ending balance | $(80,958) | $1,585 | $5,794 | $(73,579) |
| For the 40 Weeks Ended October 4, 2025 | ||||
|---|---|---|---|---|
| CurrencyTranslationAdjustments · Cash Flow Hedges | ||||
| ForwardContracts · PensionPlan · Total | ||||
| Beginning balance | $(88,684) | $1,812 | $4,268 | $(82,604) |
| Other comprehensive income (loss) before reclassifications | 22,455 | 140 | — | 22,595 |
| Amounts reclassed from accumulated other comprehensive income | — | 614 | — | 614 |
| Total other comprehensive income (loss) | 22,455 | (474) | — | 21,981 |
| Ending balance | $(66,229) | $1,338 | $4,268 | $(60,623) |
| For the 39 Weeks Ended September 28, 2024 | ||||
|---|---|---|---|---|
| CurrencyTranslationAdjustments · Cash Flow Hedges | ||||
| ForwardContracts · PensionPlan · Total | ||||
| Beginning balance | $(83,906) | $1,688 | $5,813 | $(76,405) |
| Other comprehensive income (loss) before reclassifications | 2,948 | 404 | (19) | 3,333 |
| Tax (expense) benefit | — | 68 | — | 68 |
| Amounts reclassed from accumulated other comprehensive income (loss) | — | 424 | — | 424 |
| Tax (expense) benefit | — | 151 | — | 151 |
| Total other comprehensive income (loss) | 2,948 | (103) | (19) | 2,826 |
| Ending balance | $(80,958) | $1,585 | $5,794 | $(73,579) |
See Note—10 Derivatives and Risk Management for additional disclosures about the Company’s use of derivatives.
- SEGMENT INFORMATION
The Company reports segment information based on the “management approach.” The management approach designates the internal reporting used by management, specifically its chief operating decision maker ("CODM") for making decisions and assessing performance as the source of the Company's reportable segments. The Company's CODM is its Chief Executive Officer.
The Company manages its business primarily on a geographic basis. The Company’s reportable operating segments are comprised of (i) Americas, (ii) Europe and (iii) Asia. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment primarily includes sales to customers based in Canada, Latin America and the United States. The Europe segment primarily includes sales to customers based in European countries, the Middle East and Africa. The Asia segment primarily includes sales to customers based in Australia, greater China (including mainland China, Hong Kong,
Macau and Taiwan), India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment provides similar products and services.
The Company evaluates the performance of its reportable segments based on net sales and operating income (loss). Net sales for geographic segments are based on the location of the selling entity. Operating income (loss) for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Corporate includes peripheral revenue generating activities from factories and intellectual property and general corporate expenses, including certain administrative, legal, accounting, technology support costs, equity compensation costs, payroll costs attributable to executive management, brand management, product development, art, creative/product design, marketing, strategy, compliance and back office supply chain expenses that are not allocated to the various segments because they are managed at the corporate level internally. The Company does not include intercompany transfers between segments for management reporting purposes.
The CODM uses net sales and operating income (loss) for each segment predominantly in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for both performance measures when making decisions about the allocation of operating and capital resources to each segment. The CODM also uses segment gross profit for evaluating pricing strategy and segment operating income (loss) to assess the performance of each segment by comparing the results of each segment with one another. The CODM does not review disaggregated assets by segment, therefore it is not presented below.
Summary information by operating segment was as follows (in thousands):
| For the 13 Weeks Ended October 4, 2025 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Net sales | $109,734 | $91,149 | $68,986 | $332 | $270,201 |
| Cost of sales | 53,826 | 34,492 | 28,254 | 21,203 | 137,775 |
| Gross profit | $55,908 | $56,657 | $40,732 | $(20,871) | $132,426 |
| Marketing | 8,200 | 6,935 | 5,678 | 11,032 | 31,845 |
| Compensation and benefits | 14,191 | 18,182 | 8,034 | 24,503 | 64,910 |
| Depreciation and amortization | 655 | 627 | 332 | 1,698 | 3,312 |
| Other segment items (1) | 13,053 | 10,152 | 7,910 | 22,924 | 54,039 |
| Operating income (loss) | $19,809 | $20,761 | $18,778 | $(81,028) | $(21,680) |
| For the 13 Weeks Ended September 28, 2024 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Net sales | $121,333 | $97,053 | $68,978 | $455 | $287,819 |
| Cost of sales | 54,896 | 39,938 | 29,177 | 21,576 | 145,587 |
| Gross profit | $66,437 | $57,115 | $39,801 | $(21,121) | $142,232 |
| Marketing | 13,213 | 7,974 | 3,926 | 8,693 | 33,806 |
| Compensation and benefits | 16,851 | 17,133 | 8,532 | 29,533 | 72,049 |
| Depreciation and amortization | 845 | 740 | 633 | 1,533 | 3,751 |
| Other segment items (1) | 13,602 | 7,909 | 10,334 | 25,241 | 57,086 |
| Operating income (loss) | $21,926 | $23,359 | $16,376 | $(86,121) | $(24,460) |
| For the 40 Weeks Ended October 4, 2025 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Net sales | $303,214 | $235,651 | $183,746 | $1,271 | $723,882 |
| Cost of sales | 139,800 | 89,581 | 70,993 | 21,360 | 321,734 |
| Gross profit | $163,414 | $146,070 | $112,753 | $(20,089) | $402,148 |
| Marketing | 16,389 | 13,855 | 12,929 | 12,948 | 56,121 |
| Compensation and benefits | 44,250 | 54,890 | 25,152 | 82,647 | 206,939 |
| Depreciation and amortization | 2,074 | 2,116 | 1,333 | 4,052 | 9,575 |
| Other segment items (1) | 37,730 | 14,270 | 24,601 | 72,851 | 149,452 |
| Operating income (loss) | $62,971 | $60,939 | $48,738 | $(192,587) | $(19,939) |
| For the 39 Weeks Ended September 28, 2024 | |||||
|---|---|---|---|---|---|
| Americas | Europe | Asia | Corporate | Total | |
| Net sales | $350,935 | $250,625 | $199,713 | $1,420 | $802,693 |
| Cost of sales | 171,451 | 104,328 | 92,673 | 21,667 | 390,119 |
| Gross profit | $179,484 | $146,297 | $107,040 | $(20,247) | $412,574 |
| Marketing | 34,922 | 17,972 | 17,316 | 10,576 | 80,786 |
| Compensation and benefits | 50,535 | 56,423 | 26,931 | 88,344 | 222,233 |
| Depreciation and amortization | 2,999 | 2,603 | 1,731 | 4,722 | 12,055 |
| Other segment items (1) | 45,744 | 28,588 | 32,860 | 77,977 | 185,169 |
| Operating income (loss) | $45,284 | $40,711 | $28,202 | $(201,866) | $(87,669) |
(1)Other segment items for each reportable segment include long-lived asset impairments, restructuring charges, facility costs, overhead expenses, fixed asset disposals and other operating costs.
The following table reflects net sales for each class of similar products in the periods presented (in thousands, except percentage data):
| For the 13 Weeks Ended October 4, 2025 | For the 13 Weeks Ended September 28, 2024 | |||
|---|---|---|---|---|
| Net Sales | Percentage of Total | Net Sales | Percentage of Total | |
| Watches: | ||||
| Traditional watches | $222,204 | 82.2% | $223,248 | 77.6% |
| Smartwatches | 3,832 | 1.4 | 3,968 | 1.4 |
| Total watches | $226,036 | 83.6% | $227,216 | 79.0% |
| Leathers | 15,094 | 5.6 | 23,946 | 8.3 |
| Jewelry | 25,057 | 9.3 | 31,459 | 10.9 |
| Other | 4,014 | 1.5 | 5,198 | 1.8 |
| Total | $270,201 | 100.0% | $287,819 | 100.0% |
| For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 | |||
|---|---|---|---|---|
| Net Sales | Percentage of Total | Net Sales | Percentage of Total | |
| Watches: | ||||
| Traditional watches | $585,280 | 80.9% | $603,897 | 75.2% |
| Smartwatches | 9,277 | 1.3 | 21,237 | 2.6 |
| Total watches | $594,557 | 82.2% | $625,134 | 77.8% |
| Leathers | 49,221 | 6.8 | 78,695 | 9.8 |
| Jewelry | 66,708 | 9.2 | 81,922 | 10.2 |
| Other | 13,396 | 1.8 | 16,942 | 2.2 |
| Total | $723,882 | 100.0% | $802,693 | 100.0% |
- DERIVATIVES AND RISK MANAGEMENT
Cash Flow Hedges. Historically, the Company entered into forward contracts to manage the risk of fluctuations in global currencies that were ultimately used by non-U.S. dollar functional currency subsidiaries to settle payments of intercompany inventory transactions denominated in U.S. dollars and fluctuations in Japanese yen exchange rates that were used to settle third-party inventory component purchases by a U.S. dollar functional currency subsidiary. Forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed-upon settlement date and exchange rate. These forward contracts were designated as single cash flow hedges. Fluctuations in exchange rates will either increase or decrease the Company’s U.S. dollar equivalent cash flows from these inventory transactions, which will affect the Company’s U.S. dollar earnings. Gains or losses on the forward contracts were expected to offset these fluctuations to the extent the cash flows were hedged by the forward contracts.
For a derivative instrument that is designated and qualifies as a cash flow hedge, the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (loss), net of taxes and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.
As of October 4, 2025, the Company hadno outstanding forward contracts designated as cash flow hedges. As of December 28, 2024, the fair value amount on a gross basis for the Company’s derivative instruments was $0.6 million and was included in prepaid expenses and other current assets in the condensed consolidated balance sheets.
Hedges. The Company also periodically enters into forward contracts to manage exchange rate risks associated with certain intercompany transactions and for which the Company does not elect hedge accounting treatment. As of October 4, 2025 and December 28, 2024 the Company didnot have any non-designated forward contracts outstanding. Changes in the fair value of derivatives not designated as hedging instruments are recognized in earnings when they occur.
The gains and losses on cash flow hedges that were recognized in other comprehensive income (loss), net of taxes are set forth below (in thousands):
| For the 13 Weeks Ended September 28, 2024 | |
|---|---|
| Cash flow hedges: | |
| Forward contracts | $(648) |
| Total gain (loss) recognized in other comprehensive income (loss), net of taxes | $(648) |
| For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 | |
|---|---|---|
| Cash flow hedges: | ||
| Forward contracts | $140 | $472 |
| Total gain (loss) recognized in other comprehensive income (loss), net of taxes | $140 | $472 |
The following tables disclose the gains and losses on derivative instruments recorded in accumulated other comprehensive income (loss), net of taxes during the term of the hedging relationship and reclassified into earnings, and gains and losses on derivatives not designated as hedging instruments recorded directly to earnings (in thousands):
| Derivative Instruments | Condensed ConsolidatedStatements of Income (Loss)and ComprehensiveIncome (Loss) Location | Effect of DerivativeInstruments | For the 13 Weeks Ended October 4, 2025 | For the 13 Weeks Ended September 28, 2024 |
|---|---|---|---|---|
| Forward contracts designated as cash flow hedging instruments | Cost of sales | Total gain (loss) reclassified from accumulated other comprehensive income (loss) | $— | $159 |
| Forward contracts designated as cash flow hedging instruments | Other income (expense)-net | Total gain (loss) reclassified from accumulated other comprehensive income (loss) | $— | $49 |
| Forward contracts not designated as hedging instruments | Other income (expense)-net | Total gain (loss) recognized in income | $(7) | $(20) |
| Derivative Instruments | Condensed ConsolidatedStatements of Income (Loss)and ComprehensiveIncome (Loss) Location | Effect of DerivativeInstruments | For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 |
|---|---|---|---|---|
| Forward contracts designated as cash flow hedging instruments | Cost of sales | Total gain (loss) reclassified from accumulated other comprehensive income (loss) | $— | $153 |
| Forward contracts designated as cash flow hedging instruments | Other income (expense)-net | Total gain (loss) reclassified from accumulated other comprehensive income (loss) | $614 | $422 |
| Forward contracts not designated as hedging instruments | Other income (expense)-net | Total gain (loss) recognized in income | $12 | $(5) |
The following tables summarize the effects of the Company's derivative instruments on earnings (in thousands):
| Effect of Derivative Instruments | ||||
|---|---|---|---|---|
| For the 13 Weeks Ended October 4, 2025 | For the 13 Weeks Ended September 28, 2024 | |||
| Cost of Sales | Other Income (Expense)-net | Cost of Sales | Other Income (Expense)-net | |
| Total amounts of income and expense line items presented in the condensed consolidated statements of income (loss) and comprehensive income (loss) in which the effects of cash flow hedges are recorded | $137,775 | $(6,231) | $145,587 | $3,617 |
| Gain (loss) on cash flow hedging relationships: | ||||
| Forward contracts designated as cash flow hedging instruments: | ||||
| Total gain (loss) reclassified from other comprehensive income (loss) | $— | $— | $159 | $49 |
| Forward contracts not designated as hedging instruments: | ||||
| Total gain (loss) recognized in income | $— | $(7) | $— | $(20) |
| Effect of Derivative Instruments | ||||
|---|---|---|---|---|
| For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 | |||
| Cost of Sales | Other Income (Expense)-net | Cost of Sales | Other Income (Expense)-net | |
| Total amounts of income and expense line items presented in the condensed consolidated statements of income (loss) and comprehensive income (loss) in which the effects of cash flow hedges are recorded | $321,734 | $(9,536) | $390,119 | $8,955 |
| Gain (loss) on cash flow hedging relationships: | ||||
| Forward contracts designated as cash flow hedging instruments: | ||||
| Total gain (loss) reclassified from other comprehensive income (loss) | $— | $614 | $153 | $422 |
| Forward contracts not designated as hedging instruments: | ||||
| Total gain (loss) recognized in income | $— | $12 | $— | $(5) |
- FAIR VALUE MEASUREMENTS
The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.
ASC 820, Fair Value Measurement and Disclosures (“ASC 820”), establishes a fair value hierarchy, which prioritizes the inputs used in measuring fair value into three broad levels as follows:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Inputs, other than quoted prices in active markets, that are observable either directly or indirectly.
Level 3 — Unobservable inputs based on the Company’s assumptions.
ASC 820 requires the use of observable market data if such data is available without undue cost and effort.
As of October 4, 2025, the Company did not have any assets or liabilities measured at fair value on a recurring basis.
The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of December 28, 2024 (in thousands):
| Fair Value at December 28, 2024 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Assets: | ||||
| Forward contracts | $— | $580 | $— | $580 |
| Total | $— | $580 | $— | $580 |
The fair values of the Company’s forward contracts are based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. See Note 10—Derivatives and Risk Management, for additional disclosures about the forward contracts.
As of October 4, 2025, the Company's Notes (as defined in Note 15— Debt Activity), excluding unamortized debt issuance costs, were recorded at cost and had a carrying value of $150.0 million and had a fair value of approximately $109.9 million. The fair value of the Company's Notes was based on Level 1 inputs. The Company's New Revolving Facility (as defined in Note 15—Debt Activity) was recorded at cost and had a carrying value of $21.0 million and its fair value approximated its carrying value. The fair value of the Company's New Revolving Facility was based on Level 3 inputs.
During the Year to Date Period, operating lease right-of-use ("ROU") assets with a carrying amount of $1.6 million were written down to a fair value of $1.0 million, resulting in impairment charges of $0.6 million. During the Prior Year YTD Period, ROU assets with a carrying amount of $3.9 million and property, plant and equipment-net with a carrying value of $0.6 million were written down to a fair value of $2.6 million and $0.3 million, respectively, resulting in impairment charges of $1.6 million.
The fair values of operating lease ROU assets and fixed assets related to retail stores were determined using Level 3 inputs, including forecasted cash flows and discount rates. Of the $0.6 million impairment expense in the Year to Date Period, $0.6 million was recorded in other long-lived asset impairments in the Americas segment. Of the $1.6 million impairment expense in the Prior Year YTD Period, $1.0 million, $0.5 million and $0.1 million was recorded in other long-lived asset impairments in the Asia, Europe and Americas segments, respectively.
- INTANGIBLE AND OTHER ASSETS
The following table summarizes intangible and other assets (in thousands):
| October 4, 2025 · December 28, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Useful · Gross · Accumulated · Gross · Accumulated | ||||||||
| Lives · Amount · Amortization · Amount · Amortization | ||||||||
| Intangibles-subject to amortization: | ||||||||
| Trademarks | 10 yrs. | $3,978 | $3,437 | $3,978 | $3,360 | |||
| Patents | 3 - 20 yrs. | 850 | 588 | 850 | 571 | |||
| Trade name | 6 yrs. | 4,502 | 4,502 | — | — | |||
| Other | 7 - 20 yrs. | 341 | 305 | 340 | 275 | |||
| Total intangibles-subject to amortization | 9,671 | 8,832 | 5,168 | 4,206 | ||||
| Intangibles-not subject to amortization: | ||||||||
| Trade names | 8,946 | — | ||||||
| Other assets: | ||||||||
| Deposits | 14,535 | 14,038 | ||||||
| Deferred tax asset-net | 25,443 | 23,857 | ||||||
| Restricted cash | 2,212 | 2,454 | ||||||
| Debt issuance costs | 17,589 | 1,854 | ||||||
| Other | 1,988 | 2,930 | ||||||
| Total other assets | 61,767 | 45,133 | ||||||
| Total intangible and other assets | $80,384 | $8,832 | $50,301 | $4,206 | ||||
| Total intangible and other assets-net | $71,552 | $46,095 | ||||||
During fiscal year 2024, the Company committed to a plan to sell its MICHELE and SKAGEN trade names and recorded the assets to prepaid and other during fiscal year 2024 when the qualifications for assets held for sale were met. During the Third Quarter, due to circumstances previously considered unlikely, the Company decided not to sell its trade names and reclassified the assets as held and used. The MICHELE trade name is recorded at its carrying amount before the asset was classified as held for sale. The SKAGEN trade name was recorded at its carrying amount before the asset was classified as held for sale adjusted for amortization that would have been recognized had the asset been continually classified as held and used, which resulted in the asset being fully amortized.
Amortization expense for intangible assets was $0.6 million and $0.2 million for the Third Quarter and the Prior Year Quarter, respectively, and $0.7 million and $0.7 million for the Year To Date Period and Prior Year YTD Period, respectively. Estimated aggregate future amortization expense by fiscal year for intangible assets is as follows (in thousands):
| Fiscal Year | AmortizationExpense |
|---|---|
| 2025 (remaining) | $40 |
| 2026 | $138 |
| 2027 | $120 |
| 2028 | $114 |
| 2029 | $83 |
| Thereafter | $344 |
- COMMITMENTS AND CONTINGENCIES
Litigation. The Company is occasionally subject to litigation or other legal proceedings in the normal course of its business. The Company does not believe that the outcome of any currently pending legal matters, individually or collectively, will have a material effect on the business or financial condition of the Company.
- LEASES
The Company's leases consist primarily of retail space, offices, warehouses, distribution centers, equipment and vehicles. The Company determines if an agreement contains a lease at inception based on the Company's right to the economic benefits of the leased assets and its right to direct the use of the leased asset. ROU assets represent the Company's right to use an underlying asset, and ROU liabilities represent the Company's obligation to make lease payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term. As the Company's leases do not provide an implicit rate, the Company uses its estimated incremental borrowing rate based on the information available at the commencement date adjusted for the lease term and lease country to determine the present value of the lease payments.
Some leases includeone or more options to renew at the Company's discretion, with renewal terms that can extend the lease from approximatelyone toten additional years. The renewal options are not included in the measurement of ROU assets and ROU liabilities unless the Company is reasonably certain to exercise the optional renewal periods. Short-term leases are leases having a term of twelve months or less at inception. The Company does not record a related lease asset or liability for short-term leases. The Company has certain leases containing lease and non-lease components which are accounted for as a single lease component. The Company has certain lease agreements where lease payments are based on a percentage of retail sales over contractual levels and others include rental payments adjusted periodically for inflation. The variable portion of these lease payments is not included in the Company's lease liabilities. The Company's lease agreements do not contain any significant restrictions or covenants other than those that are customary in such arrangements.
The components of lease expense were as follows (in thousands):
| Lease Cost | Condensed ConsolidatedStatements of Income (Loss)and ComprehensiveIncome (Loss) Location | For the 13 Weeks Ended October 4, 2025 | For the 13 Weeks Ended September 28, 2024 | For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 |
|---|---|---|---|---|---|
| Operating lease cost(1) | SG&A | $13,597 | $15,639 | $41,348 | $47,816 |
| Short-term lease cost | SG&A | $164 | $257 | $439 | $783 |
| Variable lease cost | SG&A | $5,096 | $5,363 | $14,059 | $16,000 |
(1)Includes sublease income, which was immaterial.
The following table discloses supplemental balance sheet information for the Company’s leases (in thousands):
| Leases | CondensedConsolidatedBalance SheetsLocation | October 4, 2025 | December 28, 2024 |
|---|---|---|---|
| Assets | |||
| Operating | Operating lease ROU assets | $122,533 | $121,389 |
| Liabilities | |||
| Current: | |||
| Operating | Current operating lease liabilities | $36,022 | $37,327 |
| Noncurrent: | |||
| Operating | Long-term operating lease liabilities | $108,645 | $113,658 |
The following table discloses the weighted-average remaining lease term and weighted-average discount rate for the Company's leases:
| Lease Term and Discount Rate | October 4, 2025 | December 28, 2024 |
|---|---|---|
| Weighted-average remaining lease term: | ||
| Operating leases | 6.1 years | 6.3 years |
| Weighted-average discount rate: | ||
| Operating leases | 15.2% | 15.1% |
Future minimum lease payments by year as of October 4, 2025 were as follows (in thousands):
| Fiscal Year | Operating Leases |
|---|---|
| 2025 (remaining) | $15,811 |
| 2026 | 54,363 |
| 2027 | 37,468 |
| 2028 | 23,951 |
| 2029 | 21,809 |
| Thereafter | 75,790 |
| Total lease payments | $229,192 |
| Less: Interest | 84,525 |
| Total lease obligations | $144,667 |
Supplemental cash flow information related to leases was as follows (in thousands):
| For the 40 Weeks Ended October 4, 2025 | For the 39 Weeks Ended September 28, 2024 | |
|---|---|---|
| Cash paid for amounts included in the measurement of lease liabilities: | ||
| Operating cash flows from operating leases | $51,113 | $55,470 |
| Leased assets obtained in exchange for new operating lease liabilities | 23,936 | 16,178 |
As of October 4, 2025, the Company did not have any material operating or finance leases that have been signed but not commenced.
- DEBT ACTIVITY
Prior Revolving Facility: On September 26, 2019, the Company and Fossil Partners L.P., as the U.S. borrowers, and Fossil Group Europe GmbH, Fossil Asia Pacific Limited, Fossil (Europe) GmbH, Fossil (UK) Limited and Fossil Canada Inc., as the non-U.S. borrowers, certain other subsidiaries of the Company from time to time party thereto designated as borrowers, and certain subsidiaries of the Company from time to time party thereto as guarantors, entered into a secured asset-based revolving credit agreement (the “Prior Revolving Facility”) with JPMorgan Chase Bank, N.A. as administrative agent (the "ABL Agent"), J.P. Morgan AG, as French collateral agent, JPMorgan Chase Bank, N.A., Citizens Bank, N.A. and Wells Fargo Bank, National Association as joint bookrunners and joint lead arrangers, and Citizens Bank, N.A. and Wells Fargo Bank, National Association, as co-syndication agents and each of the lenders from time to time party thereto (the "ABL Lenders").
New Revolving Credit Facility: On August 13, 2025, the Company and certain of its subsidiaries identified therein as guarantors entered into a Credit Agreement, dated as of August 13, 2025 (the “ABL Credit Agreement”), with the lenders from time to time party thereto (the “Lenders”), ACF FINCO I LP, as administrative agent on behalf of the Lenders (the “Administrative Agent”), and the Company as a borrower to refinance the Prior Revolving Facility. Pursuant to the Credit Agreement, the Lenders have provided new financing commitments to the Company under a new senior secured asset-based revolving credit facility (the “New Revolving Credit Facility”) in an aggregate principal amount of $150 million.
Contemporaneously with entering into the New Revolving Credit Facility, the proceeds of the New Revolving Credit Facility were used to pay off in full the $15.0 million outstanding under the Prior Revolving Facility. The Company recorded a loss of $1.7 million in other income (expense) - net during the Third Quarter for debt issuance costs and other fees associated with the Prior Revolving Facility.
Borrowings under the New Revolving Credit Facility bear interest at a rate of 5.00% for term SOFR borrowings and 4.00% for base rate borrowings, payable monthly in arrears. The Lenders received an upfront commitment fee equal to 2.00% of the aggregate commitments under the New Revolving Credit Facility. The Company’s obligations under the New Revolving Credit Facility are guaranteed by certain of the Company’s subsidiaries, and those obligations and the guarantees are secured by substantially all of the assets of the Company and certain of its subsidiaries. The ABL Credit Agreement includes customary representations and warranties, covenants applicable to the Company and events of default. If an event of default under the ABL Credit Agreement occurs, the Lenders may, among other things, declare the outstanding obligations under the ABL Credit Agreement to be immediately due and payable.
The New Revolving Credit Facility includes customary representations and warranties, covenants applicable to the Company and its restricted subsidiaries and events of default. If an event of default under the Credit Agreement occurs, the Lenders may, among other things, declare the outstanding obligations under the Credit Agreement to be immediately due and payable.
The New Revolving Credit Facility has a maturity date of August 13, 2030, subject to a springing maturity date to the date that is the 91st day prior to the scheduled maturity of any material indebtedness, as defined in the ABL Credit Agreement, if, on such 91st day, such material indebtedness remains outstanding.
Notes: In November 2021, the Company sold $150.0 million aggregate principal amount of 7.00% senior notes due November 2026 (the “Notes”), generating net proceeds of approximately $141.7 million. The Notes were issued pursuant to the indenture dated November 8, 2021 (the "Base Indenture") supplemented by a first supplemental indenture dated November 8, 2021 (together with the Base Indenture, the "Indenture") with The Bank of New York Mellon Trust Company, N.A., as trustee (the "Trustee").
The Notes are general unsecured obligations of the Company and rank equally in right of payment with all of the Company’s existing and future senior unsecured and unsubordinated indebtedness, and will rank senior in right of payment to the Company’s future subordinated indebtedness, if any. The Notes are effectively subordinated to all of the Company’s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness, and the Notes are structurally subordinated to all existing and future indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries (excluding any amounts owed by such subsidiaries to the Company). The Notes bear interest at the rate of 7.00% per annum. Interest on the Notes is payable quarterly in arrears on February 28, May 31, August 31 and November 30 of each year. The Notes mature on November 30, 2026.
The Company may redeem the Notes for cash in whole or in part at any time at its option at the following prices: (i) prior to November 30, 2025, at a price equal to $25.25 per $25.00 principal amount of Notes and (ii) on or after November 30, 2025, at a price equal to $25.00 per $25.00 principal amount of Notes, plus (in each case noted above) accrued and unpaid interest, if any, to, but excluding, the date of redemption.
The Indenture contains customary events of default and cure provisions. If an event of default (other than an event of default of the type described in the following sentence) occurs and is continuing with respect to the Notes, the Trustee may, and at the direction of the registered holders of at least 25% in aggregate principal amount of the outstanding debt securities of the Notes shall, declare the principal amount plus accrued and unpaid interest, premium and additional amounts, if any, on the Notes to be due and payable immediately. If an event of default relating to certain events of bankruptcy, insolvency or reorganization of the Company occurs, the principal amount plus accrued and unpaid interest, and premium, if any, on the Notes will become immediately due and payable without any action on the part of the Trustee or any holder of the Notes.
On November 13, 2025, as a result of the Restructuring Plan (as defined herein), all $150.0 million aggregate principal amount of the Notes outstanding were cancelled.
Fossil India Facility: During the Year To Date Period and in fiscal year 2024, Fossil India Private Ltd. entered into receivables buyout facilities that are used for working capital purposes (the "Fossil India Facilities"). Indian Rupee borrowings, in U.S. dollars, under the Fossil India Facilities were approximately $6.3 million as of October 4, 2025.
Activity: As of October 4, 2025, the Company had $150.0 million and $21.0 million outstanding under the Notes and New Revolving Facility, respectively. The Company had net borrowings of $3.0 million and net borrowings of $5.1 million under the New Revolving Credit Facility and Prior Revolving Facility during the Third Quarter and Year To Date Period, respectively. As of October 4, 2025, the Company had available borrowing capacity of $22.7 million under the New Revolving Credit Facility. As of October 4, 2025, the Company had unamortized debt issuance costs of $1.9 million recorded in long-term debt and $17.6 million recorded in intangible and other assets-net on the Company's consolidated balance sheets. The Company incurred $2.6 million and $8.1 million of interest expense related to the Notes during the Third Quarter and Year To Date Period, respectively. The Company incurred $0.4 million and $1.0 million of interest expense related to the New Revolving Credit Facility and the Prior Revolving Facility during the Third Quarter and Year To Date Period, respectively. The Company incurred $0.6 million and $1.8 million of interest expense related to the amortization of debt issuance costs during the Third Quarter and Year To Date Period, respectively. At October 4, 2025, the Company was in compliance with all debt covenants related to its credit facilities.
Notes exchange: On August 13, 2025, the Company, Fossil (UK) Global Services Ltd. ("Fossil UK”), and certain direct and indirect subsidiaries of the Company identified therein (collectively, the "Company Parties”) entered into a Transaction Support Agreement (the "Transaction Support Agreement”) with certain holders (the "Consenting Noteholders”), representing approximately 59% of the aggregate principal of the Company's Notes.
On November 13, 2025, the Company consummated the previously announced offer to exchange (the “Exchange Offer”) with respect to its Notes and its concurrent rights offering (the “Rights Offering”) pursuant to a restructuring plan under Part 26A of the UK Companies Act 2006 (as amended) (the “Restructuring Plan” and together with the Exchange Offer and the Rights Offering, the “Transactions”). See "Subsequent Events” and "Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” for a discussion of the Transactions.
- RESTRUCTURING
In fiscal 2024, the Company announced a plan to return to profitable growth (the "Turnaround Plan"). The Turnaround Plan is centered on three key areas: (i) refocusing on the core, (ii) rightsizing the cost structure, and (iii) strengthening the balance sheet. The Company expects to achieve selling, general and administrative ("SG&A") cost savings of approximately $100 million in fiscal 2025 as compared to fiscal 2024 through a series of initiatives including a strategic reduction in force which occurred in late February 2025, reduced costs associated with the transition of smaller international markets to a distributor model, and the closing of underperforming retail stores. The Company closed 44 retail stores in the Year To Date Period and plans to close an additionalsix stores in the fourth quarter of fiscal year 2025. The Company estimates approximately $60 million in total charges in connection with the Turnaround Plan, with approximately $7 million incurred in fiscal 2024 and $40 million to be incurred during fiscal 2025.
The following table shows a summary of Turnaround Plan charges (in thousands):
| For the 13 Weeks Ended October 4, 2025 | For the 40 Weeks Ended October 4, 2025 | |
|---|---|---|
| Restructuring expenses | $6,789 | $29,905 |
| Consolidated | $6,789 | $29,905 |
Turnaround Plan restructuring charges by operating segment were as follows (in thousands):
| For the 13 Weeks Ended October 4, 2025 | For the 40 Weeks Ended October 4, 2025 | |
|---|---|---|
| Americas | $58 | $1,049 |
| Europe | 1,601 | 5,246 |
| Asia | 356 | 1,442 |
| Corporate | 4,774 | 22,168 |
| Consolidated | $6,789 | $29,905 |
The following table shows a rollforward of the accrued liability related to the Company’s Turnaround Plan (in thousands):
| For the 13 Weeks Ended October 4, 2025 | |||||
|---|---|---|---|---|---|
| Liabilities · Liabilities | |||||
| July 5, 2025 | Charges | Cash Payments | Non-cash Items | October 4, 2025 | |
| Store closures | $— | $13 | $— | $13 | $— |
| Professional services | 5,976 | 3,487 | 5,876 | — | 3,587 |
| Severance and employee-related benefits | 6,079 | 3,289 | 4,428 | — | 4,940 |
| Total | $12,055 | $6,789 | $10,304 | $13 | $8,527 |
| For the 40 Weeks Ended October 4, 2025 | |||||
|---|---|---|---|---|---|
| Liabilities · Liabilities | |||||
| December 28, 2024 | Charges | Cash Payments | Non-cash Items | October 4, 2025 | |
| Store closures | $— | $23 | $— | $23 | $— |
| Professional services | — | 14,529 | 10,942 | — | 3,587 |
| Severance and employee-related benefits | — | 15,353 | 10,364 | 49 | 4,940 |
| Total | $— | $29,905 | $21,306 | $72 | $8,527 |
In fiscal year 2024, the Company concluded its Transform and Grow plan ("TAG") as it transitioned to initiatives under the Turnaround Plan. TAG was launched in early 2023 to reduce operating costs, improve operating margins, and advance the Company’s commitment to profitable growth. The Company had expanded the scope and duration of TAG to focus on a more comprehensive review of its global business operations. The expansion of TAG put greater emphasis on initiatives aimed at restructuring or optimizing operations, exiting or minimizing certain product offerings, brands and distribution channels, strengthening gross margins through improvements in sourcing and improving working capital efficiency. Under the expanded TAG plan, the Company achieved annualized operating income benefits of $280 million over the two-year period.
The following table shows a summary of TAG plan charges (in thousands):
| For the 13 Weeks Ended September 28, 2024 | For the 39 Weeks Ended September 28, 2024 | |
|---|---|---|
| Cost of sales | $— | $(241) |
| Restructuring expenses | 4,849 | 31,575 |
| Total | $4,849 | $31,334 |
TAG plan restructuring charges by operating segment were as follows (in thousands):
| For the 13 Weeks Ended September 28, 2024 | For the 39 Weeks Ended September 28, 2024 | |
|---|---|---|
| Americas | $652 | $1,174 |
| Europe | 179 | 5,531 |
| Asia | 597 | 1,830 |
| Corporate | 3,421 | 22,799 |
| Consolidated | $4,849 | $31,334 |
The following table shows a rollforward of the accrued liability related to the Company’s TAG plan (in thousands):
| For the 13 Weeks Ended October 4, 2025 | |||
|---|---|---|---|
| Liabilities · Liabilities | |||
| July 5, 2025 | Cash Payments | October 4, 2025 | |
| Charges related to exits of certain product offerings | $125 | $125 | $— |
| Total | $125 | $125 | $— |
| For the 13 Weeks Ended September 28, 2024 | ||||
|---|---|---|---|---|
| Liabilities · Liabilities | ||||
| June 29, 2024 | Charges | Cash Payments | September 28, 2024 | |
| Professional services | $11,319 | $3,667 | $11,149 | $3,837 |
| Severance and employee-related benefits | 8,349 | 1,182 | 3,656 | 5,875 |
| Charges related to exits of certain product offerings | 300 | — | — | 300 |
| Total | $19,968 | $4,849 | $14,805 | $10,012 |
| For the 40 Weeks Ended October 4, 2025 | |||
|---|---|---|---|
| Liabilities · Liabilities | |||
| December 28, 2024 | Cash Payments | October 4, 2025 | |
| Store closures | $1 | $1 | $— |
| Professional services | 9,501 | 9,501 | $— |
| Severance and employee-related benefits | 7,341 | 7,341 | — |
| Charges related to exits of certain product offerings | 300 | 300 | — |
| Total | $17,143 | $17,143 | $— |
| For the 39 Weeks Ended September 28, 2024 | |||||
|---|---|---|---|---|---|
| Liabilities · Liabilities | |||||
| December 30, 2023 | Charges | Cash Payments | Non-cash Items | September 28, 2024 | |
| Store closures | $— | $143 | $7 | $136 | $— |
| Professional services | 117 | 17,719 | 13,999 | — | 3,837 |
| Severance and employee-related benefits | 8,117 | 13,713 | 15,590 | 365 | 5,875 |
| Charges related to exits of certain product offerings | 3,821 | (241) | 3,280 | — | 300 |
| Total | $12,055 | $31,334 | $32,876 | $501 | $10,012 |
- SUBSEQUENT EVENTS
Notes Exchange: On November 13, 2025, the Company consummated the previously announced Exchange Offer and concurrent Rights Offering pursuant to the Restructuring Plan. In connection with the consummation of the Transactions:
Noteholders that participated in the Rights Offering and Exchange Offer (the “New Money Participants”) (i) provided an aggregate of $32,500,000 of incremental, new money financing in exchange for (x) $32,500,000 aggregate principal amount of 9.500% First-Out First Lien Secured Senior Notes due 2029 (the “First-Out Notes”) and (y)954,070 shares of common stock, par value $0.01 (“Common Stock”), (ii) exchanged $120,229,725 aggregate principal amount of Notes on a dollar-for-dollar basis for $120,229,725 aggregate principal amount of First-Out Notes, and (iii) received $945,946 aggregate principal amount of First-Out Notes as a consent premium pursuant to the terms of the Transactions (the “Consent Premium”).
Noteholders that did not participate in the Rights Offering (the “Non-New Money Participants”) (i) received $29,770,275 aggregate principal amount of 7.500% Second-Out Second Lien Secured Senior Notes due 2029 (the “Second-Out Notes”) on a dollar-for-dollar basis for $29,770,275 Notes held by such Non-New Money Participants, and (ii) received $53,858 aggregate principal amount of Second-Out Notes as a Consent Premium. Only Non-New Money Participants that tendered their Notes in the Exchange Offer and consented to the Restructuring Plan received the Consent Premium.
Noteholders also received an aggregate total of approximately 3,000,000 warrants (the “Warrants”), entitling the holders thereof to purchase either (i)one share of Common Stock for each Warrant held, or (ii)one pre-funded warrant (each, a “Pre-Funded Warrant”) for each Warrant held, each such Pre-Funded Warrant entitling the holder thereof to purchaseone share of Common Stock.
As a result of the Restructuring Plan, all $150,000,000 aggregate principal amount of Notes outstanding have been cancelled.
The Consenting Noteholders participated in the Transactions on a private placement basis. In accordance with the terms of the Transaction Support Agreement, the Consenting Noteholders received $1,625,000 aggregate principal amount of First-Out Notes as a backstop premium as consideration for providing a backstop commitment for the Rights Offering.
ABL Amendment: On November 13, 2025, the Company entered into a First Amendment (the “ABL Amendment”) to its ABL Credit Agreement in order to effectuate certain conforming amendments to the ABL Credit Agreement to the terms of the First-Out Notes Indenture, as further described in the ABL Amendment.
Shelf Registration: On November 13, 2025 the Company filed a Registration Statement on Form S-3 (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) using a “shelf” registration process, pursuant to which the Company may, from time to time, sell up to $150.0 million of certain securities in one or more offerings. In addition, the Company entered into an Equity Distribution Agreement with Maxim Group LLC providing for an up to $50.0 million “at the market” common stock equity offering. Pursuant to the Equity Distribution Agreement, after the Registration Statement is declared effective by the SEC, the Company may offer and sell shares of common stock from time to time at prevailing market prices up to the lesser of $50.0 million of gross proceeds or 25,000,000 shares of common stock at a minimum price of $2.00 per share. There is no assurance that the Company will sell any shares of common stock in this offering. The net proceeds of this offering, if any, will be used for working capital and general corporate purposes.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.